- Home
- PBYI vs BRY Comparison
PBYI vs BRY Comparison
Compare PBYI & BRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- BRY
- Stock Information
- Founded
- PBYI 2010
- BRY 1909
- Country
- PBYI United States
- BRY United States
- Employees
- PBYI N/A
- BRY N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- BRY Oil & Gas Production
- Sector
- PBYI Health Care
- BRY Energy
- Exchange
- PBYI Nasdaq
- BRY Nasdaq
- Market Cap
- PBYI 237.2M
- BRY 249.1M
- IPO Year
- PBYI N/A
- BRY N/A
- Fundamental
- Price
- PBYI $5.41
- BRY $3.37
- Analyst Decision
- PBYI Strong Buy
- BRY Hold
- Analyst Count
- PBYI 1
- BRY 2
- Target Price
- PBYI $7.00
- BRY $4.00
- AVG Volume (30 Days)
- PBYI 511.9K
- BRY 1.4M
- Earning Date
- PBYI 11-06-2025
- BRY 11-06-2025
- Dividend Yield
- PBYI N/A
- BRY 3.59%
- EPS Growth
- PBYI 434.29
- BRY N/A
- EPS
- PBYI 0.97
- BRY 0.07
- Revenue
- PBYI $238,062,000.00
- BRY $701,914,000.00
- Revenue This Year
- PBYI N/A
- BRY N/A
- Revenue Next Year
- PBYI N/A
- BRY N/A
- P/E Ratio
- PBYI $5.56
- BRY $51.34
- Revenue Growth
- PBYI 8.63
- BRY N/A
- 52 Week Low
- PBYI $2.32
- BRY $2.11
- 52 Week High
- PBYI $6.07
- BRY $5.90
- Technical
- Relative Strength Index (RSI)
- PBYI 65.34
- BRY 39.06
- Support Level
- PBYI $5.11
- BRY $3.60
- Resistance Level
- PBYI $5.42
- BRY $3.52
- Average True Range (ATR)
- PBYI 0.25
- BRY 0.14
- MACD
- PBYI 0.06
- BRY -0.08
- Stochastic Oscillator
- PBYI 75.36
- BRY 5.97
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.